about
Growing older with health and vitality: a nexus of physical activity, exercise and nutritionMuscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findingsRecommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaMechatronic Wearable Exoskeletons for Bionic Bipedal Standing and Walking: A New Synthetic ApproachElevated hydrogen peroxide and decreased catalase and glutathione peroxidase protection are associated with aging sarcopeniaThe Need for Standardized Assessment of Muscle Quality in Skeletal Muscle Function Deficit and Other Aging-Related Muscle Dysfunctions: A Symposium Report.Short-term strength training improves muscle quality and functional capacity of elderly womenAssociation of Low Lean Mass With Frailty and Physical Performance: A Comparison Between Two Operational Definitions of Sarcopenia-Data From the Berlin Aging Study II (BASE-II).Low back pain in older adults: risk factors, management options and future directions.A Frailty Index from Next-of-Kin Data: A Cross-Sectional Analysis from the Mexican Health and Aging Study.A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α.Translational studies in older men using testosterone to treat sarcopenia.Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014.Relationship of anabolic and catabolic biomarkers with muscle strength and physical performance in older adults: a population-based cross-sectional studyNutraceuticals for geriatricsSarcopenia and Hearing Loss in Older Koreans: Findings from the Korea National Health and Nutrition Examination Survey (KNHANES) 2010Association between Thigh Muscle Volume and Leg Muscle Power in Older Women.Physiological effects beyond the significant gain in muscle mass in sarcopenic elderly men: evidence from a randomized clinical trial using a protein-rich food.Nutritionally essential amino acids and metabolic signaling in aging.Computed tomography abbreviated assessment of sarcopenia following trauma: The CAAST measurement predicts 6-month mortality in older adult trauma patients.Low appendicular skeletal muscle mass (ASM) with limited mobility and poor health outcomes in middle-aged African AmericansWhole-body electromyostimulation as a means to impact muscle mass and abdominal body fat in lean, sedentary, older female adults: subanalysis of the TEST-III trial.Evaluation of Body Weight, Body Condition, and Muscle Condition in Cats with Hyperthyroidism.Impact of whole-body electromyostimulation on body composition in elderly women at risk for sarcopenia: the Training and ElectroStimulation Trial (TEST-III).Clinical management of chronic obstructive pulmonary disease patients with muscle dysfunction.An antibody blocking activin type II receptors induces strong skeletal muscle hypertrophy and protects from atrophy.Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis.Androgen effects on skeletal muscle: implications for the development and management of frailty.Pathophysiology of muscle dysfunction in COPD.Analysis of effects of loading and postural demands on upper limb reaching in older adults using statistical parametric mapping.Sarcopenia prevalence and factors associated with sarcopenia in older people living in a nursing home in Ankara Turkey.Frailty in Pulmonary and Critical Care MedicineSarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.Sarcopenia and the New ICD-10-CM Code: Screening, Staging, and Diagnosis Considerations.Low back pain in older adults - the need for specific outcome and psychometric toolsAge-dependent changes in skeletal muscle mass and visceral fat area in Japanese adults from 40 to 79 years-of-age.Operational definitions of sarcopenia and their associations with 5-year changes in falls risk in community-dwelling middle-aged and older adults.Promoting access to innovation for frail old persons. IAGG (International Association of Gerontology and Geriatrics), WHO (World Health Organization) and SFGG (Société Française de Gériatrie et de Gérontologie) Workshop--Athens January 20-21, 2012.Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.Age-related sarcopenia and its pathophysiological bases.
P2860
Q26765982-F5F6CE4B-E018-41A2-9CDA-233C7FD625BDQ26775701-72B81EB0-0B04-443A-B979-E66BE122760DQ28069408-715477ED-8395-4C58-849A-CD5BFAA661D1Q28074553-E3C9C278-7BD9-4C44-BF9D-5363211BBBFEQ28392374-15686DA0-7113-4418-AACA-52FE16CE0AABQ30235428-B4AE2966-88A0-456C-9FF1-291787E4E3B7Q30419606-2DD5FF8A-C605-4580-9592-922D9B19B1D0Q30886859-8C07D565-7F07-4AB6-9874-435200AA267DQ33576918-5F42FA35-7C2D-490F-A55E-63E26923984BQ33630973-C103354B-655E-4338-A49D-AAA5E8720732Q33901304-0E6E0E94-32B1-48F7-BAB9-9B118A1E8558Q33957794-44D41662-7949-4DDD-8FEF-6533DD8ACE0BQ34591010-DD2B6D6D-A196-48E7-958B-185C809FFA69Q35749690-47178B2E-6F94-4112-A76D-1F7DE294BCC6Q35807099-75C84DE4-1EB9-49CC-B27C-5A5E36F047A4Q35957935-5ECAC1CC-75A8-4882-A30E-3996D3469C33Q36055477-3EB34857-862C-4C8A-A1A8-573C04C23575Q36136244-84A93CAE-8E06-4654-A5FC-7D8A48E04318Q36746472-16A6A42C-CDA2-4A84-91FB-F58E98D0E72DQ36823206-7D75C8EC-478A-4802-821F-82AA5CE1AB14Q37176475-D2950475-5DE8-43F9-A039-E3E144E51F5EQ37226907-76EDFA9E-0BD4-4B28-82F6-E481B23A3B86Q37422778-58D6F2CB-7130-427C-A349-D098B182FA00Q37471006-FB0EED93-C3A7-4091-BDAC-5198C0636064Q37528272-F39C9680-372C-484D-974C-30355617B75FQ37546849-AB0ED781-F71B-4FA3-92A7-33A6C013B056Q37595990-C7442DE8-7ADE-4045-80B6-2BB6FB8835A5Q37639192-223AC08C-4222-4C30-80B4-5B712F1A6664Q38091961-0F78CC0D-CADF-49E6-9505-B2EA09CCF5CDQ39583817-F8FEBA81-2DEB-4601-95A5-9583EF12DC45Q40302880-9E88E4B0-4D01-4604-BA3C-92C787A7E19BQ40786235-A6A22888-A096-494B-B0DA-FE865E704776Q41431020-D10F312A-F9BB-4BE3-AA73-F62C24F5A618Q41556895-0BE18FE5-E515-4F91-BC8A-3B2760A22EB3Q42368958-11D14376-7A65-423B-B9C8-EC792B7039A6Q43812963-E60AEC2A-E9F4-4BC0-8686-E51AAA382D88Q44316815-32A4EBD6-6FCE-4411-93EB-CE849E4C476CQ45760984-0316E5DA-2416-441A-A7D6-494F91544E34Q47100877-DF2D4698-03D9-413C-96BE-EF31921D16C8Q47135931-8A6A63BC-2A9F-4CFF-9C60-E93329EF651B
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Sarcopenia in the elderly.
@en
Sarcopenia in the elderly.
@nl
type
label
Sarcopenia in the elderly.
@en
Sarcopenia in the elderly.
@nl
prefLabel
Sarcopenia in the elderly.
@en
Sarcopenia in the elderly.
@nl
P2860
P356
P1433
P1476
Sarcopenia in the elderly.
@en
P2093
John E Morley
P2860
P304
P356
10.1093/FAMPRA/CMR063
P407
P478
29 Suppl 1
P577
2012-04-01T00:00:00Z